Gainers
- OncoCyte OCX stock increased by 57.5% to $0.31 during Thursday's regular session. Trading volume for this security as of 13:30 EST is 4.8 million, which is 1766.1% of its average full-day volume over the last 100 days. The company's market cap stands at $37.3 million.
- Corbus Pharmaceuticals CRBP shares moved upwards by 38.48% to $4.03. Trading volume for this security as of 13:30 EST is 1.3 million, which is 1913.4% of its average full-day volume over the last 100 days. The company's market cap stands at $16.8 million.
- Baudax Bio BXRX shares rose 37.59% to $1.83. Trading volume for Baudax Bio's stock is 5.8 million as of 13:30 EST. This is 365.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.7 million.
- Genelux GNLX stock moved upwards by 36.42% to $25.79. Genelux's stock is trading at a volume of 151.4K shares as of 13:30 EST. This is 79.8% of its average full-day volume over the last 100 days. The company's market cap stands at $607.7 million.
- Lipella Pharmaceuticals LIPO stock increased by 32.24% to $2.42. As of 13:30 EST, this security is trading at a volume of 21.4 million shares, making up 3888.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.9 million.
- ThermoGenesis Holdings THMO shares moved upwards by 30.23% to $5.46. As of 13:30 EST, ThermoGenesis Holdings's stock is trading at a volume of 24.3 million, which is 4126.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.6 million.
Losers
- Esperion Therapeutics ESPR stock declined by 47.7% to $2.08 during Thursday's regular session. The current volume of 47.4 million shares is 2287.0% of Esperion Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $159.3 million.
- Paratek Pharmaceuticals PRTK shares declined by 29.06% to $1.35. Trading volume for Paratek Pharmaceuticals's stock is 2.3 million as of 13:30 EST. This is 979.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $75.2 million. As per the news, the Q4 earnings report came out today.
- Gossamer Bio GOSS stock decreased by 18.19% to $1.08. As of 13:30 EST, this security is trading at a volume of 3.2 million shares, making up 85.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $102.0 million.
- Kezar Life Sciences KZR stock declined by 16.92% to $3.83. As of 13:30 EST, Kezar Life Sciences's stock is trading at a volume of 1.0 million, which is 184.0% of its average full-day volume over the last 100 days. The company's market cap stands at $271.1 million. The company's, Q4 earnings came out 2 days ago.
- HeartBeam BEAT shares decreased by 14.92% to $2.51. HeartBeam's stock is trading at a volume of 105.0K shares as of 13:30 EST. This is 182.4% of its average full-day volume over the last 100 days. The company's market cap stands at $20.1 million. As per the press release, Q4 earnings came out today.
- Eloxx Pharmaceuticals ELOX shares fell 12.53% to $2.55. The market value of their outstanding shares is at $5.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in